Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1979 1
1982 5
1983 1
1984 5
1985 7
1986 14
1987 22
1988 19
1989 26
1990 38
1991 31
1992 21
1993 28
1994 24
1995 28
1996 35
1997 26
1998 19
1999 15
2000 22
2001 23
2002 26
2003 16
2004 16
2005 16
2006 21
2007 22
2008 12
2009 24
2010 16
2011 19
2012 25
2013 30
2014 22
2015 26
2016 18
2017 18
2018 20
2019 18
2020 11
2021 14
2022 15
2023 14
2024 19
2025 9

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

804 results

Results by year

Filters applied: . Clear all
Page 1
Sexual side effects of serotonergic antidepressants: mediated by inhibition of serotonin on central dopamine release?
Bijlsma EY, Chan JS, Olivier B, Veening JG, Millan MJ, Waldinger MD, Oosting RS. Bijlsma EY, et al. Pharmacol Biochem Behav. 2014 Jun;121:88-101. doi: 10.1016/j.pbb.2013.10.004. Epub 2013 Oct 12. Pharmacol Biochem Behav. 2014. PMID: 24128918 Review.
By comparing the effects of these mechanistically distinct antidepressants (paroxetine, venlafaxine, bupropion, buspirone, DOV 216,303 and S32006), this review discusses the putative mechanism underlying sexual side effects of antidepressants and their …
By comparing the effects of these mechanistically distinct antidepressants (paroxetine, venlafaxine, bupropion, buspirone, DOV …
Drugs for Depression.
[No authors listed] [No authors listed] Med Lett Drugs Ther. 2020 Feb 24;62(1592):25-32. Med Lett Drugs Ther. 2020. PMID: 32320387 No abstract available.
Evaluation of the safety and side effects of antianxiety agents.
Schnabel T Jr. Schnabel T Jr. Am J Med. 1987 May 22;82(5A):7-13. doi: 10.1016/0002-9343(87)90197-5. Am J Med. 1987. PMID: 2884874 Free article. Review.
Historically, the use of anxiolytic drugs has been associated with a relatively high incidence of side effects, particularly those related to central nervous system depression and sedation. These side effects can impair the patient's ability to functio …
Historically, the use of anxiolytic drugs has been associated with a relatively high incidence of side effects, particularly t …
A Serotonin "Cocktail".
Nunes JC, Botas JL. Nunes JC, et al. Prim Care Companion CNS Disord. 2020 Jul 2;22(4):19l02532. doi: 10.4088/PCC.19l02532. Prim Care Companion CNS Disord. 2020. PMID: 32628370 Free article. No abstract available.
Buspirone: anxiolytic?
Pecknold JC, Familamiri P, Chang H, Wilson R, Alarcia J, McClure DJ. Pecknold JC, et al. Prog Neuropsychopharmacol Biol Psychiatry. 1985;9(5-6):639-42. doi: 10.1016/0278-5846(85)90032-6. Prog Neuropsychopharmacol Biol Psychiatry. 1985. PMID: 2868495 Clinical Trial.
Dizziness was the most prominent adverse effect in the buspirone group, whereas the diazepam group had more adverse effects including sedation, fatigue, dizziness and impaired concentration. Withdrawal symptoms were more evident in the diazepam group t …
Dizziness was the most prominent adverse effect in the buspirone group, whereas the diazepam group had more adverse …
Buspirone: future directions.
Apter JT, Allen LA. Apter JT, et al. J Clin Psychopharmacol. 1999 Feb;19(1):86-93. doi: 10.1097/00004714-199902000-00014. J Clin Psychopharmacol. 1999. PMID: 9934947 Review.
The Food and Drug Administration approved the use of buspirone for generalized anxiety disorder (GAD) in 1986. Since then, numerous studies have examined the efficacy and safety of buspirone for patients with not only generalized feelings of anxiety, but also panic …
The Food and Drug Administration approved the use of buspirone for generalized anxiety disorder (GAD) in 1986. Since then, numerous s …
Anxiolytic antidepressant augmentation.
Sussman N. Sussman N. J Clin Psychiatry. 1998;59 Suppl 5:42-8; discussion 49-50. J Clin Psychiatry. 1998. PMID: 9635547 Review.
On the other hand, the anxiolytic agent buspirone does facilitate direct antidepressant response, largely through its ability to activate both presynaptic and postsynaptic 5-HT1A receptors and thus modulate serotonin release. Several case studies and open-label trials have …
On the other hand, the anxiolytic agent buspirone does facilitate direct antidepressant response, largely through its ability to acti …
Buspirone: what is it all about?
Loane C, Politis M. Loane C, et al. Brain Res. 2012 Jun 21;1461:111-8. doi: 10.1016/j.brainres.2012.04.032. Epub 2012 Apr 24. Brain Res. 2012. PMID: 22608068 Review.
The underlying mechanism of action of buspirone is not clear; however it is thought that its main pharmacology is mediated via the 5-HT(1A) receptors. Initially developed for use in the treatment of generalised anxiety disorder, it appears that buspirone may be usef …
The underlying mechanism of action of buspirone is not clear; however it is thought that its main pharmacology is mediated via the 5- …
Venlafaxine-induced galactorrhea.
Sternbach H. Sternbach H. J Clin Psychopharmacol. 2003 Feb;23(1):109-10. doi: 10.1097/00004714-200302000-00023. J Clin Psychopharmacol. 2003. PMID: 12544389 No abstract available.
Buspirone overdose.
Tiller JW, Burrows GD, O'Sullivan BT. Tiller JW, et al. Med J Aust. 1989 Jan 2;150(1):54. doi: 10.5694/j.1326-5377.1989.tb136355.x. Med J Aust. 1989. PMID: 2909855 No abstract available.
804 results